Renaissance Technologies’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.05M | Buy |
+48,800
| New | +$4.05M | 0.01% | 1653 |
|
|
2025
Q1 | – | Sell |
-5,500
| Closed | -$495K | – | 3890 |
|
|
2024
Q4 | $495K | Buy |
+5,500
| New | +$495K | ﹤0.01% | 2848 |
|
|
2023
Q2 | – | Sell |
-18,200
| Closed | -$1.39M | – | 4316 |
|
|
2023
Q1 | $1.39M | Buy |
+18,200
| New | +$1.39M | ﹤0.01% | 2249 |
|
|
2022
Q4 | – | Sell |
-4,100
| Closed | -$325K | – | 4460 |
|
|
2022
Q3 | $325K | Sell |
4,100
-7,100
| -63% | -$563K | ﹤0.01% | 3178 |
|
|
2022
Q2 | $832K | Sell |
11,200
-41,100
| -79% | -$3.05M | ﹤0.01% | 2831 |
|
|
2022
Q1 | $4.7M | Buy |
+52,300
| New | +$4.7M | 0.01% | 1636 |
|
|
2020
Q3 | – | Sell |
-26,900
| Closed | -$3.01M | – | 3745 |
|
|
2020
Q2 | $3.01M | Buy |
+26,900
| New | +$3.01M | ﹤0.01% | 1932 |
|